[Cell death in malignant tumors. Relevance of cell death regulation for metastasis]

W Roth1

  • 1Pathologisches Institut, Deutsches Krebsforschungszentrum Heidelberg, Universität Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Deutschland. wilfried.roth@med.uni-heidelberg.de.

Der Pathologe
|September 25, 2015
PubMed

Insights

Properly regulated cell death prevents cancer metastasis and therapy resistance. Understanding cell death mechanisms is crucial for developing new cancer treatments.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Defects in cell death regulation contribute to malignant tumor development and treatment resistance.
  • Distinct cell death types, including apoptosis, anoikis, and necroptosis, are known.
  • Cell death plays a critical role in preventing cancer metastasis.

Purpose of the Study:

  • To explore the role of cell death regulation in preventing metastasis.
  • To investigate the links between cell death pathways and metastasis at the subcellular level.
  • To highlight the implications of cell death dysregulation in therapy resistance.

Main Methods:

  • Review of recent studies on cell death and metastasis.
  • Analysis of signaling pathways and proteins involved in both processes.
  • Examination of specific examples like decoy receptor 3 (DcR3).

Main Results:

  • Cell death is pivotal in preventing various steps of the metastasis cascade.
  • Proteins like DcR3 can promote tumor cell invasion and migration while inhibiting apoptosis.
  • Metastasis involves selection for therapy-resistant phenotypes.

Conclusions:

  • Targeting cell death mechanisms is crucial for preventing metastasis.
  • Dysregulated cell death contributes to therapy-resistant metastatic cancers.
  • Development of diagnostic tests and resistance-overcoming strategies is needed.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K